Spain Oncology Therapeutics Market Analysis

Spain Oncology Therapeutics Market Analysis


$ 3999

By 2030, the Spain Oncology Therapeutics Market is anticipated to reach a value of $6.2 Bn from $3.5 Bn in 2022, growing at a CAGR of 7.4% during 2022-30. The Oncology Therapeutics Market in Spain is dominated by a few domestic pharmaceutical companies such as PharmaMar, Grifols, and Oryzon Genomics. The Oncology Therapeutics Market in Spain is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Spain Oncology Therapeutics is increasing due to the rise in initiatives taken by the country's government.

ID: IN10ESPH042 CATEGORY: Pharmaceuticals GEOGRAPHY: Spain AUTHOR: Dr. Vishwa Modhia

Buy Now

Spain Oncology Therapeutics Market Analysis Summary

By 2030, it is anticipated that the Spain Oncology Therapeutics Market will reach a value of $6.2 Bn from $3.5 Bn in 2022, growing at a CAGR of 7.4% during 2022-30.

Spain is a high-income developed country located in Southwestern Europe. The coastlines include the Bay of Biscay, the Mediterranean Sea, and the Northern Atlantic Ocean. Cancer is the second leading cause of mortality in Spain, trailing only cardiovascular illness. However, everything points to cancer seizing the lead in the near future. According to the International Agency for Research on Cancer, the number of new cancer cases in Spain in 2020 was 282421. In 2020, the number of cancer deaths in Spain was 113054.

The risk of developing cancer before the age of 75 is 27.7%. The SNS's fundamental ideals are "universal," "equal," and "free." Most of the cancer care is delivered in large university hospitals that are owned and funded by the government. Spain’s government spent 10.7 % of its GDP on healthcare in 2020.

Spain Oncology Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

The rising number of cancer cases is mostly related to smoking, a practice that began to proliferate among Spanish women 20 years ago. In Spain, smoking is fairly common. One in every four Spaniards smokes cigarettes on a daily basis, and another 25% of the Spanish population is a former smoker. However, disease-related deaths have been steadily declining since 1995. This is most likely owing to an increase in early detection and improved therapies. Breast cancer and colon cancer screening programmes are well-established, while prostate cancer screening lags behind. In addition, new cancer drugs are being approved by the European Medicines Agency (EMA). In Spain, all EMA-approved cancer drug costs are reimbursed by the Spanish National Health System (SNS), although some local restrictions have been a matter of concern in recent times. These aspects could boost Spain Oncology Therapeutics Market.

Market Restraints

Smoking cessation (especially among adolescents and women), improved access to genetic screening, and reduced treatment inequities are all essential and pressing future challenges. Spain is very vulnerable to pandemic-risk industries. It has a skewed labour market and a high structural unemployment rate. These factors may deter new entrants into the Spain Oncology Therapeutics Market.

Competitive Landscape

Key Players

  • PharmaMar: PharmaMar is a Spanish biopharmaceutical company that specializes in the development of marine-based cancer therapeutics. The company is currently developing several innovative marine-derived anticancer drugs
  • Grifols: Grifols is a Spanish multinational pharmaceutical and life sciences company that develops and produces a range of cancer therapeutics, including plasma-derived products, immunoglobulins, and haematology products
  • Oryzon Genomics: Oryzon Genomics is a Spanish biotechnology company that specializes in the development of epigenetic cancer therapeutics. The company is currently developing several innovative epigenetic therapies for a range of cancer types
  • Almirall: Almirall is a Spanish pharmaceutical company that focuses on the development and production of a range of cancer therapeutics, including chemotherapy drugs, targeted therapies, and immunotherapies

Notable Recent Deals

November 2022: After a failed clinical trial, the United States has removed an innovative new cancer medication that had recently been integrated into Spain's health system. Following the failure of a recent clinical trial, the US Food and Drug Administration (FDA) has ordered British pharmaceutical giant GlaxoSmithKline (GLK) to suspend sales of the novel cancer medication Blenrep. The medicine was banned in the United States barely two months after it was approved in Spain for patients who experienced relapses after completing all available therapies for multiple myeloma.

July 2022: Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging oncological epigenetics to develop therapies in diseases with high unmet medical needs, announced the start of a preclinical collaboration with the CMT Research Foundation (CMTRF), a patient-led, non-profit organisation based in the United States focused on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease, to investigate Oryzon's HDAC6 inhibitors.

Healthcare Policies and Reimbursement Scenarios

Spain's citizens have access to cancer treatments through its national healthcare system. The nation's drug approval and regulation are handled by the Spanish Agency of Medicines and Medical Devices (AEMPS). The Spanish Public Health System (SNS)'s Pricing and Reimbursement (PR) is then established by the Inter-Ministerial Commission for the Pricing of Medicines (CIPM). Spain also has a special system for assessing and reimbursing innovative cancer treatments called the "Plan for Scientific and Technical Research and Innovation." This system allows patients with life-threatening or serious diseases, including cancer, to access treatments that have not yet been approved for use in Spain.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Therapeutics Segmentation

By Application (Revenue, USD Billion):

  • Blood Cancer
  • ?Colorectal Cancer
  • Gastrointestinal Cancer
  • Gynaecologic Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • ?Others

By Drugs (Revenue, USD Billion):

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Temodar
  • Others

By Therapy (Revenue, USD Billion):

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 30 January 2024
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up